治疗药物监测已死,目标浓度干预长存!
Twenty years ago, target concentration intervention (TCI) was distinguished from therapeutic drug monitoring (TDM). It was proposed that TCI would bring more clinical benefit because of the precision of the approach and the ability to link TCI to principles of pharmacokinetics an…
要点
- TCI基于药代动力学和药效学原理预测个体所需剂量,较TDM更精准。
- 临床试验证据支持TCI较TDM带来更多临床获益。
- 在数字时代,TDM应被放弃并由TCI替代。
核心结论
- 在数字时代,治疗药物监测(TDM)应被放弃并由目标浓度干预(TCI)替代。
主要发现
- TCI方法具有精准性,并能与药代动力学和药效学原理结合以预测个体所需剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Twenty years ago, target concentration intervention (TCI) was distinguished from therapeutic drug monitoring (TDM). It was proposed that TCI would bring more clinical benefit because of the precision of the approach and the ability to link TCI to principles of pharmacokinetics and pharmacodynamics to predict the dose required by an individual (1). We examine the theory and clinical trial evidence supporting the benefits of TCI over TDM and conclude that in the digital age TDM should be abandoned and replaced by TCI.
引用
- Holford N, Ma G, Metz D, et al. TDM is dead. Long live TCI! Br J Clin Pharmacol. 2020. PMID: 32543717. doi:10.1111/bcp.14434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。